A PYMNTS Company

France: Latest pharma deal sees Synerlab buyout

By  |  November 20, 2013

In the latest deal in the highly active pharmaceutical market, private equity firm 21 Partners has announced plans to acquire France-based pharmaceutical manufacturer Synerlab.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Financial details of the deal were not reported, but the deal involves Synerlab’s current owner Ardian reinvesting in the company in efforts to promote Synerlab’s expansion throughout the EU.

    The merger remains subject to antitrust clearance.

    Full Content: VCPost

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.